Aimmune Therapeutics, Inc. Cash on Hand 2015-2020 | AIMT
Aimmune Therapeutics, Inc. cash on hand from 2015 to 2020. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Aimmune Therapeutics, Inc. Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2019 | $144 |
| 2018 | $304 |
| 2017 | $182 |
| 2016 | $249 |
| 2015 | $192 |
| 2014 | $2 |
| 2013 | $12 |
| Aimmune Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2020-06-30 | $314 |
| 2020-03-31 | $358 |
| 2019-12-31 | $144 |
| 2019-09-30 | $195 |
| 2019-06-30 | $244 |
| 2019-03-31 | $283 |
| 2018-12-31 | $304 |
| 2018-09-30 | $255 |
| 2018-06-30 | $290 |
| 2018-03-31 | $322 |
| 2017-12-31 | $182 |
| 2017-09-30 | $212 |
| 2017-06-30 | $237 |
| 2017-03-31 | $246 |
| 2016-12-31 | $249 |
| 2016-09-30 | $150 |
| 2016-06-30 | $169 |
| 2016-03-31 | $180 |
| 2015-12-31 | $192 |
| 2015-09-30 | $217 |
| 2015-06-30 | $59 |
| 2015-03-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
